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Abstract
This study describes six yeast strains for stereoselective ketone reductions. The reaction conditions for the yeast strains (Pichia carsonii, 
Lodderomyces elongisporus, Candida norvegica, Candida guillermondi, Debaromyces fabryi and Candida parapsilosis) were optimized 
in a design of experiments for three ketones of different properties. The pH tolerance, temperature stability and productivity of the 
bioreductions with lyophilized cells of the yeast strains were characterized. In several cases, the optimized bioreductions resulted 
in enantiopure alcohols (ee > 99 %) with conversions ranging from moderate to excellent.
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1 Introduction
Whole-cell biocatalysts are easily applicable biomaterials 
which can be used in various fields such as food indus-
try, agriculture, and fine chemical industry including the 
pharmaceutical industry. Whole-cell biocatalysts have 
several advantages over isolated enzymes [1]. Since whole 
cells have several sets of metabolic enzymes, they can be 
utilized in various types of reactions with different sub-
strates. It is also possible to use the same whole-cell bio-
catalyst to produce different products, and by-products can 
be back-converted into main product with properly chosen 
reaction conditions. The production process with whole-
cells is robust and beneficial because it does not require 
costly processes like enzyme purification steps [2].
The application of whole-cell biocatalysts in ste-
reoselective biotransformations have been increasing 
for the past decades. The growing need of chiral Active 
Pharmaceutical Ingredients (APIs) creates a demand for 
novel and promising biocatalysts, such as yeasts [3–5]. 
There are plenty of APIs that possess chiral secondary 
hydroxyl groups, such as ezetimibe [6], fluoxetine [7], 
aprepitant [8] and atorvastatin [9]. The ketoreductase 
enzyme family is extensively researched and utilized 
as biocatalysts to create enantiopure alcohols from the 
corresponding prochiral ketones [5].
Yeasts are important industrial microorganisms 
because their production is simpler than that of recom-
binant bacterial cells. Furthermore, wild-type yeasts 
contain several metabolic pathways involving enzymes 
which can be applied to produce enantiopure compounds. 
Yeasts have already been applied successfully in acy-
loin condensation [10], bioreductions and amine produc-
tion [11], as well as acylation of alcohols and amines [12]. 
Most yeasts harbor several ketoreductases (KREDs) with 
different properties. Because of the presence of multi-
ple KRED activities, fine tuning of the reaction condi-
tions for every employed ketone substrate is needed to 
achieve ideal productivity and selectivity. The most rel-
evant parameters of optimization are pH, cosubstrate 
for co-factor regeneration, temperature and cosolvent. 
Planned Design of Experiments (DOE) are the best choice 
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for investigating the significant parameters (effects and 
their interactions) of the reaction conditions to achieve 
the optimum for each bioreduction [13, 14].
Efficient cofactor regeneration is an indispensable step 
to realize successful ketoreduction because KREDs per-
form the ketone reduction with nicotinamide adenine 
dinucleotide (NADH) or nicotinamide adenine dinucleo-
tide phosphate (NADPH) as external cofactor or the alco-
hol oxidation with the oxidized form of these cofactors 
( NAD+ or NADP+ ) [15, 16]. In the case of industrial-scaled 
bioreductions, it is advisable to use small and cheap cos-
ubstrates for regeneration of the external cofactor, such as 
2-propanol, glucose, sodium formate or lactose [5].
Several yeast strains have already been published 
as robust biocatalysts in stereoselective bioreductions 
resulting in industrially relevant, optically pure alco-
hols and alcohol derivatives. Lodderomyces elongisporus 
immobilized in sol-gel matrix proved to be a competent 
and switchable biocatalyst for ketone reduction and acy-
loin condensation [17]. Pichia glucozyma showed high 
activity with several monosubstituted acetophenone deriv-
atives, and catalyzed the bioreduction of several aromatic 
ketones such as with pyridyl, furanyl, thienyl aromatic 
ring and also ketoesters [18–20].  Rhodotorula mucilag-
inosa turned out to be a good candidate for the bioreduc-
tion of acetophenone derivatives in the presence of glucose 
co-substrate as well [21].  Wickerhamomyces subpellicu-
losus–another yeast strain showing efficient biocatalytic 
properties in the form of wet and lyophilized cells–could 
transform several simple ketones and a ketone with aryl 
and cyclopropyl moieties [22]. Meyerozyma guilliermondii 
isolated from marine environment and Rhodotorula muci-
laginosa showed high molar conversion and good enan-
tioselectivity in the bioreduction of acetophenone deriv-
atives and β-ketonitriles [23]. Yarrowia lipolytica strains 
were tested on several mono- or disubstituted acetophe-
none derivatives performing bioreductions in moderate 
to good conversions, although with weak enantiomeric 
excess [24]. Candida parapsilosis is a widely studied yeast 
strain capable of acting on a broad substrate palette as effi-
cient whole-cell biocatalyst [25–27].
Our paper presents optimized conditions of enantio-
tope selective bioreductions of three ketones 1a-c (com-
prising aryl, aralkyl and alkyl substituents) by lyophilized 
whole-cells of six different yeast strains. To achieve the 
best conversion and enantiomeric excess for each of the 
ketones (1a-c), several reaction parameters (pH, tem-
perature, cosubstrate amount) were optimized with DOE. 
This study also demonstrated the usefulness of the novel 
yeast strains in preparative scale bioreduction of ketones 
to enantiopure (S)-alcohols.
2 Experimental
2.1 Reagents and yeast strains
The substrates [1-phenylpropan-2-one (1a), acetophenone 
(1b), and heptan-2-one (1c)], the reagents and the solvents 
were purchased from Merck (Darmstadt, Germany) and 
Alfa Aesar Europe (Karlsuhe, Germany).
Yeast strains investigated in this study (Pichia carsonii 
(WY1), Lodderomyces elongisporus (WY2), Candida 
norvegica (WY4), Candida guillermondi (WY7), 
Debaromyces fabryi (WY11) and Candida parapsilosis 
(WY12)) originated from the Witaria strain culture col-
lection. The yeast strains were prepared and lyophilized 
as described earlier [22, 28].
2.2 Analytical methods
The NMR spectra were recorded in CDCl3 on a Bruker 
DRX-300 spectrometer operating at 300 MHz for 1H and 
75 MHz for 13C, and signals are given in ppm on the δ scale. 
Infrared spectra were recorded on a Bruker ALPHA FT-IR 
spectrometer and wavenumbers of bands are listed in cm−1. 
Optical rotation was measured on Perkin-Elmer 241 polarim-
eter at the D-line of sodium. The polarimeter was calibrated 
with measurements of both enantiomers of menthol.
Gas chromatography was used to determine the conver-
sion and the enantiomeric excess of the bioreductions from 
ketones 1a-c. Measurements were performed on 4890 GC 
equipment, Agilent with FID detector and Hydrodex 
β-6TBDM column [25 m × 0.25 mm × 0.25 µm film with 
heptakis-(2,3-di-O-methyl-6-O-t-butyldimethylsilyl)-β-
cyclodextrin; Macherey & Nagel (Düren, Germany)] using 
H2 carrier gas (injector: 250 °C, detector: 250 °C, head 
pressure: 12 psi, split ratio: 50:1). The temperature pro-
gram and retention times are included in Table 1. Samples 
taken from the reaction mixture (150 µL for WY2, WY7 
and WY11; and 500 µL for WY1, WY4 and WY12) were 





1a 80 °C (5 min); 2 °C min
−1 up to 
120 °C 18.3 21.7 22.3
1b 120 °C (10 min) 3.4 6.5 6.9
1c 40 °C (65 min) 19.6 53.6 55.5
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extracted with ethyl acetate (1 mL) and the organic layer 
was dried over sodium sulfate for 10 minutes. The samples 
in the EtOAc-extract were analyzed directly.
2.3 Reaction conditions and evaluation method
Optimization of the bioreduction conditions for the 
selected model ketones 1a-c were planned with the DOE 
module of Statistica software. The following factors were 
investigated: lyophilized biocatalyst amount, co-substrate 
volume, buffer strength, temperature, and pH. The DOEs 
were designed and evaluated with Statistica 13 software 
for every strain–substrate combinations. The results were 
assessed with the Effect Estimates and Fitted Surface visu-
alization. The first run of the optimization was designed 
in a 2(5−2) design with foldover and triplicates in the center 
points. The curvatures and the significances of effects and 
interactions were evaluated. The investigated parameters 
have been considered to have no significant effect on the 
conversion or enantiomer excess if the p-values were above 
0.05. Then, a second run of optimization with DOE was 
designed with 22 or 23 full factorial model with triplicates 
in the center points. The values of the significant reaction 
parameter were adjusted based on the results of the first 
optimization round. If the curvature check showed signif-
icant result (p < 0.05) the DOE was completed to a DOE 
of 32. In the quadratic models both the linear and the qua-
dratic effects were evaluated.
Reactions with the strains WY1, WY4 and WY12 
were done in 5 mL volume, reactions with the strains 
WY2, WY7 and WY11 were performed in 1 mL volume. 
Reactions were carried out at 6 mg mL−1 substrate concen-
tration in sodium phosphate buffer with lyophilized yeast 
cells as biocatalysts in the presence of 2-propanol as cos-
ubstrate. The reaction mixtures were shaken at 300 rpm for 
4 h except for the productivity profiling where the samples 
were taken after 15 min. The lower, center point and higher 
values of the investigated parameters (determined by a set 
of preliminary experiments) were as follows: lyophilized 
biocatalyst concentration: 20; 30 and 40 mg mL−1; cosub-
strate concentration: 4; 5 and 6 % v/v; buffer strength: 32; 
64 and 96 mM; temperature: 30; 35 and 40 °C and pH: 6; 7 
and 8. In the second stage of the optimization, parameters 
were re-evaluated where needed. Table 2 shows the opti-
mal reaction setups (where the maximal conversions were 
achieved) for every yeast strain and substrate.
After the optimization, we characterized the biocata-
lytic properties of the yeast strains in bioreduction of the 
three ketones 1a-c by pH tolerance, temperature stability 
and substrate loading. For the property-profiling tests, 
the optimal reactions conditions were applied (Table 2). 
The pH profiles were investigated from pH 2 to 13, the 
temperature profiles were examined from 25 to 60 °C. 
The substrate-loading profile was studied between 2 and 
20 mg mL−1 substrate concentration.
2.4 Production of (S)-2a and (S)-2c on preparative scale
Lyophilized Debaromyces fabryi cells (1500 mg) were 
suspended in a 100 mL Erlenmeyer flask in sodium phos-
phate buffer (pH 7, 25 mL, 64 mM): To the cell suspension 
were added the substrate (1a or 1c, 150 mg) and 2-pro-
panol (4 % v/v for 1a; 8 % v/v for 1c) and the resulted 
mixture was shaken at 150 rpm for 24 h (for 1a at 27 °C, 
for 1c at 30 °C). Then the mixture was extracted with 
EtOAc (3 × 20 mL), the unified organic layers were dried 
on sodium sulfate and concentrated under reduced pres-
sure. The resulting product was purified by plate chroma-
tography (silica gel; eluent: hexane-EtOAc 10:4) to yield 
the enantiopure secondary alcohol [(S)-2a or (S)-2c].
(S)-2a: yield: 66 %; conversion: 70 % (determined 
with GC); ee: 99.9 % (by GC); colorless oil; Rf : 0.53; 
α[ ]D
25  = +38.2 ( c 1.0, CHCl3 ); lit.: α[ ]D
25  = +48.1 (c 1.0, 
benzene) [29]; IR (film): 3356, 2986, 1453, 1116, 1078, 936, 
740, 697 and 504 cm−1; 1H-NMR (CDCl3 , 300 MHz) δ ppm: 
Table 2 Optimal reaction conditions of the bioreductions of ketones 



















1a 40 3 35 7 97
1b 40 4 30 7 83
1c 40 4 30 7 84
WY2
1a 30 4 30 8 74
1b 30 2 30 7 38
1c 30 4 30 8 75
WY4
1a 40 8 30 7 81
1c 40 8 30 7 83
WY7 1c 30 4 30 8 26
WY11
1a 30 4 27 7 68
1b 30 2 27 7 35
1c 30 8 30 7 84
WY12
1a 20 3 35 7 97
1b 20 4 30 7 82
1c 20 4 35 7 83
a Strains: Pichia carsonii (WY1), Lodderomyces elongisporus (WY2), 
Candida norvegica (WY4), Candida guillermondi (WY7), 
Debaromyces fabryi (WY11) and Candida parapsilosis (WY12)
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1.3 ( d, J = 6.1 Hz, 3H CH3 ), 1.8 (s, 1H, OH), 2.7-2.8 ( m, 2H, 
CH2 ), 4.1 (m, 1H, CH), 7.3-7.4 (m, 5H, Ar-H); 
13C-NMR 
(CDCl3 , 75 MHz) δ ppm: 22.8 ( CH3 ), 45.8 (CH), 98.9 (CH), 
126.1 (Ph), 128.59 (Ph), 129.5 (Ph), 130.6 (Ph). 1H and 
13C NMR data agreed with the reported spectra [30].
(S)-2c: yield: 81 %; conversion: 83 % (determined 
with GC); ee: 99.9 % (by GC); colorless liquid; Rf : 0.71; 
α[ ]D
25  = +11.6 ( c 1.0, CHCl3 ); lit.: α[ ]D
25  = +12.1 (c 0.66, 
ethanol) [31], α[ ]D
25  = +10.4 ( c 0.52, CHCl3 ) [32]; IR (film): 
3332, 2959, 2927, 2859, 1459, 1375, 1112 and 950 cm−1; 
1H-NMR (CDCl3 , 300 MHz) δ ppm: 0.9 ( t, J = 6.4 Hz, 
CH3 ); 1.2 ( d, J = 6.4 Hz, CH3 ); 1.3-1.5 ( m, 6H, C3H6 ); 
1.6 (s, 1H, OH); 3.8 (m, 1H, CH); 13C-NMR (CDCl3 , 
75 MHz) δ ppm: 14.2 ( CH3 ), 22.8 ( CH2 ), 23.6 ( CH3 ), 
25.6 ( CH2 ), 32.0 ( CH2 ), 39.5 ( CH2 ), 69.4 (CH). IR and 
1H-NMR data agreed with the reported spectra [33].
3 Results and discussion
The six yeast strains investigated in this study [(Pichia 
carsonii (WY1), Lodderomyces elongisporus (WY2), 
Candida norvegica (WY4), Candida guillermondi (WY7), 
Debaromyces fabryi (WY11) and Candida parapsilosis 
(WY12)] were chosen from the Witaria strain collection 
to demonstrate the usability and adaptability of the yeasts 
as whole-cell biocatalysts in ketoreductions. The lyo-
philized yeast cells have excellent long-term storage sta-
bility which makes them robust biocatalysts [28]. All of 
the yeast strains were tested in bioreductions of three 
model ketones with different molecular properties [phe-
nylacetone (1a: a ketone with a methyl and an aralkyl sub-
stituents), acetophenone (1b: a ketone with a methyl and 
an aryl substituents), and 2-heptanone (1c: a ketone with a 
methyl and a larger alkyl substituents)] (Fig. 1). The lyo-
philized biocatalysts were tested just after the preparation 
and after storage for six months at 4 °C. Activity tests with 
1a (except WY7 with 1c) as substrate revealed less than 
5 % decrease of conversion (1 %, 2 %, 2 %, 5 %, 3 %, and 
1 % with WY1, WY2, WY4, WY7, WY11, WY12, respec-
tively) of the bioreductions after the half year long storage.
Efficient cofactor regeneration is an essential require-
ment to perform efficient bioreductions with high conver-
sion (Fig. 1). In this study, the so-called coupled-substrate 
strategy involving a cheap cosubstrate transformed by the 
same biocatalyst in opposite reaction direction was applied 
using 2-propanol as a cheap and easy-to-handle alcohol.
The following reaction parameters were investigated 
in the optimization of the bioreduction conditions: lyo-
philized biocatalyst mass, co-substrate volume, buffer 
strength, temperature, and pH. The significance of the 
investigated parameters was calculated according to the 
DOE. The initial optimization was made in a 2(5-2) DOE with 
foldover for all yeast strains and substrates. The results 
showed that the buffer strength was not a significant 
parameter, but the other parameters had diverse signifi-
cance in the distinct reaction assemblies. Not all examined 
biocatalysts could utilize all substrates, WY4 and WY7 
did not transform acetophenone 1b and WY7 did not con-
vert phenylacetone 1a. The second round of the optimiza-
tion was performed with 22, 23 and 32 DOE to achieve the 
maximal conversion for the bioreduction of each substrate. 
When conversion of the yeast-cell-based bioreductions of 
ketones 1a-c exceeded 10 % under the optimal reaction 
conditions, the corresponding (S)-alcohol (S)-2a-c was 
produced in high enantiopurity (ee > 99.5 %). We have 
investigated the bioreductions after 4 h and 24 h (when 
the reactions reached stationary state). Under the optimal 
reaction parameters, there were no significant differences 
between conversion data after 4 h and 24 h reaction time.
For industrial application of biocatalysts, the pH-range 
of operation and the optimum pH are of high importance. 
The pH profile of each yeast strain with each substrate was 
examined in the pH-range from 2 to 12 (Fig. 2). The prod-
uct formation from ketones 1a and 1c with the strains 
P. carsonii (WY1) and C. parapsilosis (WY12) was com-
parable in a wide pH-range (between 5 to 10). The biore-
duction activity of L. elongisporus (WY2) on ketones 
1a-c was optimal between pH 7 and 10 (conversion in the 
60–80 % range from 1a and 1c, and in the 20–40 % range 
from 1b). The optimal pH was 7 for bioreduction of 1a 
and 1c with C. norvegica (WY4). The weakest conversion 
Fig. 1 Bioreduction of ketones 1a-c into enantiopure alcohols (S)-2a-c 
with 2-propanol-mediated coupled-substrate cofactor regeneration
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(~20 %) from 1c was observed with C. guillermondi (WY7) 
between pH 7 and 10. D. fabryi (WY11) showed optimal 
biocatalytic activity with 1c at pH 7 achieving a conversion 
of 85.7 % which higher than c = 82.6 % with C. parapsilo-
sis being one of the most commonly applied yeast strains 
for biocatalysis. Wild-type form of Yarrowia lipolytica 
was used in the bioconversion of acetophenone 1b to create 
(R)-2b with 91–93 % conversion and with 90 % enantio-
meric excess [24]. Wickerhamomyces subpelliculosus was 
used in the synthesis of (S)-2a with conversion 95–99 % 
and with enantiomeric excess higher than 99 %. The same 
yeast strain could catalyze the bioreduction of (S)-1c with 
55 % conversion and 99.5 % enantiomeric excess [22].
Thermal stability of the bioreduction activity of the lyo-
philized yeast strains was investigated between 25 and 
60 °C (Fig. 3). With all yeast strains in this study tem-
perature optima of the bioreduction of ketones 1a-c were 
between 27–35 °C. The least thermostable strains were 
L. elongisporus (WY2) and C. guillermondi (WY7) as their 
bioreduction activity decreased rapidly over the optimal 
30 °C. The biocatalytic activity of P. carsonii (WY1), 
C. norvegica (WY4), and D. fabryi (WY11) decreased 
significantly only above 40 °C. The most thermotolerant 
was C. parapsilosis (WY12) up to 55 °C (conversion of 1a 
decreased from 95 % at 35 °C only to 78 % at 55 °C whereas 
conversion of 1b and 1c remained almost constant).
Dependence of the activity on substrate concentration 
is an important aspect influencing directly the space-time 
yield achievable with a biocatalyst. In most cases, satura-
tion concentration of the productivity above 5 mM could 
be observed (Fig. 4).
The bioreduction of phenylacetone 1a to enantiopure 
(S)-1-phenylpropan-2-ol (S)-2a with P. carsonii (WY1) 
and C. norvegica (WY4) could be carried out with similar 
maximal productivity ( 10–15 μmol g−1 min−1 ). A produc-
tivity of 28 μmol g−1 min−1 with C. parapsilosis (WY12), 
and 40 μmol g−1 min−1 with L. elongisporus (WY2) could 
be achieved. The highest productivity ( 60 μmol g−1 min−1 ) 
of the bioreduction from 1a was realized with D. fabryi 
(WY11) between substrate concentrations of 4 and 8 mM. 
The decay of bioreduction productivity from 1a above 
10 mM substrate concentration with L. elongisporus 
(WY2) and D. fabryi (WY11) indicated significant sub-
strate / product inhibition of these strains. The only strain 
which could not reduce 1a was C. guillermondi (WY7).
No bioreduction happened from acetophenone 1b 
with C. norvegica (WY4) and C. guillermondi (WY7). 
The production of enantiopure (S)-1-phenylethanol 
(S)-2b by reduction of 1b with P. carsonii (WY1) pro-
ceeded with low productivity ( 5 μmol g−1 min−1 ). 
About twice of this productivity ( ~10–15 μmol g−1 min−1 ) 
could be reached with L. elongisporus (WY2), D. fabryi 
Fig. 2 Dependence of the conversion ketones 1a-c with yeast strains on the pH [Pichia carsonii (WY1), Lodderomyces elongisporus (WY2), 
Candida norvegica (WY4), Candida guillermondi (WY7), Debaromyces fabryi (WY11) and Candida parapsilosis (WY12)] in bioreduction of 
ketones [blue square: phenylacetone (1a), orange circle: acetophenone (1b), green triangle: 2-heptanone (1c)]
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Fig. 3 Temperature tolerance of the yeast strains [Pichia carsonii (WY1), Lodderomyces elongisporus (WY2), Candida norvegica (WY4), Candida 
guillermondi (WY7), Debaromyces fabryi (WY11) and Candida parapsilosis (WY12)] in bioreduction of ketones [blue square: phenylacetone (1a), 
orange circle: acetophenone (1b), green triangle: 2-heptanone (1c)]
Fig. 4 Dependence of the productivity and conversion in the bioreduction of ketones 1a-c on the substrate concentration [blue square: phenylacetone 
(1a), orange circle: acetophenone (1b), green triangle: 2-heptanone (1c); continuous line: productivity; dashed line: conversion] in bioreductions 
with various yeast strains [Pichia carsonii (WY1), Lodderomyces elongisporus (WY2), Candida norvegica (WY4), Candida guillermondi (WY7), 
Debaromyces fabryi (WY11) and Candida parapsilosis (WY12)]
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(WY11) and C. parapsilosis (WY12). All the effective 
strains indicated substrate / product inhibition of the 
reduction above 2–4 mM concentration of 1b.
Production of (S)-heptan-2-ol (S)-2c from the aliphatic 
ketone 1c happened with all six investigated yeast strains. 
Moderate productivity ( 5–8 μmol g−1 min−1 ) could be 
reached with P. carsonii (WY1) and C. guillermondi (WY7). 
The C. norvegica (WY4) and C. parapsilosis (WY12) 
strains could reach higher productivity ( ~20 μmol g−1 min−1 ) 
in bioreduction of 1c without serious substrate / product 
inhibition. The highest 45–50 μmol g−1 min−1 productivity 
of the (S)-2c formation could be reached with L. elongis-
porous (WY2) and D. fabryi (WY11), although at differ-
ent substrate concentrations (above 10 mM with WY2 but 
at 4 mM with WY11). Only the strain D. fabryi (WY11) 
exhibited serious substrate / product inhibition in the biore-
duction of 1c above 4 mM substrate concentration.
To demonstrate the real synthetic usefulness of the 
yeast strains in this study, D. fabryi (WY11) was used to 
prepare (S)-2a and (S)-2c on preparative scale under the 
optimal reaction conditions. In the bioreduction of ketone 
1a using 4 % v/v 2-propanol as cosubstrate 76 % isolated 
yield of (S)-2a (ee = 99.9 %) was achieved. The ketone 1c 
was also transformed to (S)-2c (ee = 99.9 %) in presence 
of 8 % v/v 2-propanol cosubstrate in 81 % isolated yield.
4 Conclusion
This study indicated that lyophilized yeast cells having 
excellent long-term storage stability are easy-to-handle 
biocatalysts for ketoreductions resulting in cost-effective 
synthesis like with recombinant enzymes. The bioreduc-
tion conditions were optimized for three different ketones 
with six different yeast strains by using extensive Design 
of Experiments. Our results highlighted that P. carsonii 
exhibited better bioreduction activity on 2-heptanone and 
phenylacetone in a wide pH range as the well-character-
ized C. parapsilosis strain. Furthermore, the production of 
(S)-1-phenylpropan-2-ol (S)-2a and (S)-heptan-2-ol (S)-2c 
by bioreduction with L. elongisporus and D. fabryi could 
be achieved with twice of the productivity than that of 
achievable with C. parapsilosis. The lyophilized form of 
D. fabryi proved to be an efficient biocatalyst in the pro-
duction of enantiopure (S)-1-phenylpropan-2-ol (S)-2a and 
(S)-heptan-2-ol (S)-2c on preparative scale.
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